Fraud, abuse and overpayment increases annual claims costs by up to 10% annually, but if addressed with a comprehensive fraud control program, could be money returned to the bottom line.
Fraud, Abuse And overpayment increases annual claims costs by up to 10% annually, but if addressed with a comprehensive fraud control program, could be money returned to the bottom line.
"Provider and member fraud can drive up the price of healthcare and diminish the quality of care," says David Deaton, a partner in O'Melveny & Myers LLP's Los Angeles office and a member of the Health Care and Life Sciences Practice. "An effective fraud control program can lower premiums, increase quality for members, make healthcare coverage more accessible and protect the financial viability of a health plan."
Experts say that fighting fraud and abusive billing practices is a continually evolving process-not a single event. "In order to fight fraud effectively, you need to understand that fraud is a moving target, constantly changing and evolving. Once you've uncovered one fraudulent scheme, the most sophisticated perpetrators have moved on to a new scheme," explains Brian Smith, HCI's senior vice president of sales. "ASPs [application service providers] and SaaS [software as a service] solutions are allowing health plans to use advanced analytics, similar to what the banking industry has used for decades, to apply rules-based logic in order to prevent overpayments and detect aberrant and fraudulent provider billing trends."
A comprehensive fraud, abuse and overpayment program can typically save MCOs 1% to 5% annually. The range depends on the cost controls currently in place and the action level of the MCO. "Some MCOs are more aggressive when it comes to recovering or preventing loss attributed to fraud and abuse, and some opt to monitor and educate providers," Johnson says.
The most common fraud schemes include:
-Tracey Walker
Commentary is independent of source data
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
New PTSD Treatment Shows Promise with Brexpiprazole, Sertraline Combination
December 24th 2024Currently, the only medications approved by the FDA for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. However, these medications don’t work for everyone.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
How the Contact Center Can Be a Driver of VBC Success
December 23rd 2024Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for conveying information to patients and plan members. Today, however, AI-enabled contact centers can be drivers of value, especially in a value-based care environment.
Read More